PC
ROIV icon

PointState Capital’s Roivant Sciences ROIV Stock Holding History

PointState Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,791,440
Closed -$27.1M – 72
2025
Q3 		$27.1M Sell
1,791,440
-635,123
-26% -$7.86M 0.49% 42
2025
Q2 		$27.3M Sell
2,426,563
-288,560
-11% -$3.13M 0.59% 43
2025
Q1 		$27.4M Sell
2,715,123
-582,326
-18% -$6.3M 0.6% 42
2024
Q4 		$39M Sell
3,297,449
-810,403
-20% -$9.58M 0.89% 35
2024
Q3 		$47.4M Sell
4,107,852
-376,846
-8% -$4.29M 1.3% 27
2024
Q2 		$47.4M Buy
4,484,698
+438,213
+11% +$4.8M 1.35% 34
2024
Q1 		$42.6M Buy
+4,046,485
New +$43.6M 1.28% 38

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.27B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return